The in-vitro antimicrobial effect of non-antibiotics and putative inhibitors of efflux pumps on Pseudomonas aeruginosa and Staphylococcus aureus

International Journal of Antimicrobial Agents

Volumn 22, Issue 3, 2003, Pages 262-264

  Hendricks, O ^a   Butterworth, T S ^a   Kristiansen, J E ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Antibiotic resistance; Non antibiotics; Putative inhibitors of efflux pumps

Indexed keywords

ANTIINFECTIVE AGENT; CHLOROETHANE; PHENOTHIAZINE DERIVATIVE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DILUTION; DRUG EFFECT; EFFUSION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STEREOCHEMISTRY;

EID: 0042835368     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00205-X     Document Type: Article

References (12)

1. Kristiansen J.E. Chlorpromazine: non-antibiotics with antimicrobial activity - new insights in managing resistence? Curr. Opin. Invest. Drugs. 2:1993;587-591.
2. Kristiansen J.E., Mortensen I. Stereo-isomeric dissociation of the antibacterial and the neuroleptic effect of clopenthixol. Acta Pathol. Microbiol. Scand. Sect. B. 89:1981;437-438.
3. Ericsson H, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Act Pathol Microbiol Scand B 1971;Suppl 217:1.
4. Finney D.J. Statistical methods of biological assay. Biomol. Z. Lond. 524:1952;23-56.
5. Heinemann J.A. How antibiotics cause antibiotic resistance. Drug Discov. Today. 4:1999;72-79.
6. Ordway D., Viveiros M., Leandro C., Arroz M.J., Amaral L. Intracellular activity of clinical concentrations of phenothiazines including thioridazine against phagocytosed Staphylococcus aureus. Int. J. Antimicrob. Agents. 20:2002;34-43.
7. Kaatz G.W., Seo S.M., O'Brien L., Wahiduzzaman M., Foster T.J. Evidence for the existence of a multidrug efflux transporter distinct from NorA in S. aureus. Antimicrob. Agents Chemother. 44:2000;1404-1406.
8. Kaatz GW, Mougdal VV, Seo SM, Kristiansen JE. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus (SA). 42nd ICAAC, San Diego, California, September 2002, Abstract C1-426.
9. Molnar J., Hever A., Fakla I., Fischer J., Ocsovski I., Aszalos A. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells. Anticancer. Res. 17:1997;481-486.
10. Legakis N.J., Tzouvelekis L.S., Makris A., Kostifaki H. Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin. Antimicrob. Agents Chemother. 33:1989;124-127.
11. Livermore D.M. Of Pseudomonas, porins, pumps and carbapenems. J. Antimicrob. Chemother. 47:2001;247-250.
12. Aires J.R., Pechere J.C., Van Delden C., Kohler T. Amino acid residues essential for function of the MexF efflux pump protein of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:2002;2169-2173.